| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Pharvaris N.V.'s insiders have reduced their positions by a net 559,502 shares worth roughly $20.4M.
Classified under Biotechnology (Healthcare sector), PHVS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 650.0K | $22.75M | - | |
| Dir | 115.2K | $4.17M | - | |
| CFO | 113.8K | - | - | |
| Pres | 110.0K | $3.42M | - | |
| Other | 74.0K | $2.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Monges Viviane | Director | Sale+OE | 11,969 | $33.05 | $395,523.98 | -68.5% | - | - | |
| Sep 22, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sale+OE | 800 | $36.19 | $28,952.00 | -0.7% | - | - | |
| Sep 21, 2026 | Nassif David W. | CFO / CLO | Sell | 6,000 | $36.47 | $218,800.80 | -5.0% | - | - | |
| Sep 17, 2026 | Bjork Elisabeth | Director | Sale+OE | 52,500 | $37.89 | $1,989,408.75 | -77.6% | - | - | |
| Sep 17, 2026 | Glassman Robert | Director | Sale+OE | 14,493 | $38.56 | $558,812.40 | -58.0% | - | - | |
| Sep 17, 2026 | Lesage Anne | Chief Early Development | Sell | 20,000 | $38.27 | $765,466.00 | -21.3% | - | - | |
| Sep 17, 2026 | Lu Peng | President | Sale+OE | 100,000 | $35.00 | $3,500,000.00 | -60.6% | - | - | |
| Sep 17, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell | 200,000 | $35.00 | $7,000,000.00 | -63.5% | - | - | |
| Sep 15, 2026 | Abele Stefan Andreas | Chief Technical Ops Officer | Sale+OE | 46,400 | $38.17 | $1,771,125.04 | -54.3% | - | - | |
| Sep 15, 2026 | Glassman Robert | Director | Sale+OE10b5-1 | 8,667 | $38.27 | $331,716.42 | -45.2% | - | - |